GSI 705 (Truvada 167 mg / 250 mg)
Generic Name: emtricitabine/tenofovir
Pill imprint GSI 705 has been identified as Truvada 167 mg / 250 mg.
Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 167 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Truvada (emtricitabine / tenofovir)
- Other brands: AccessPak for HIV PEP Basic
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.